Fair value (multi-method)
Four independent methods triangulate what CLX is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$88.75
Method range
$12.57 – $210.19
median $97.28
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $88.75 | -7.32% |
| Exit multiple | $210.19 | +119.50% |
| Analyst target | $105.80 | +10.48% |
| Graham number | $12.57 | -86.87% |
- Forward DCF$88.75
- Exit multiple$210.19
- Analyst target$105.80
- Graham number$12.57
Stock price
$95.76
EPS (TTM)
$6.16
5Y EPS CAGR
-2.4%
Fair value @ hist. growth
$88.75
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied EPS growth
-1.4%
per year over your projection horizon
Margin of safety -7.9% vs hist-growth DCF
Historical 5Y CAGR
-2.4%
Your model implies
-1.4%
Next-year analyst consensus
-2.6%
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.3% | -4.9% | -5.9% | -7.2% | -8.7% | -10.6% |
| 6.3% | -2.3% | -3.1% | -4.0% | -5.1% | -6.4% |
| 7.3% | 0.0% | -0.7% | -1.4% | -2.3% | -3.2% |
| 8.3% | 2.1% | 1.5% | 0.9% | 0.2% | -0.6% |
| 9.3% | 4.0% | 3.5% | 3.0% | 2.4% | 1.7% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.87
Low vs growth
Net debt
$2.71B
Total debt − cash
Beta
0.53
Vs market benchmark
Annual diluted EPS
Per-share earnings by fiscal year — last 5 years anchor the CAGR reference above.
Frequently asked questions
Clorox (CLX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.63% TTM
- Dividend Profile5.18% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.